American Heart Association

Dr. Mauricio Gonzalez Selects Fastlane as Agency of Record

Retrieved on: 
torsdag, april 18, 2024
American Diabetes Association, Health, Heart, Diabetes, Exercise, AARP, Hypertension, Quality of life, Organization, American Heart Association

NEW YORK, April 18, 2024 /PRNewswire-PRWeb/ -- Dr. Mauricio Gonzalez, best known as Dr. Mau, an award-winning, triple board-certified physician in internal, emergency, and obesity medicine based in New York City, has selected Fastlane as the agency of record (AOR) for his rapidly-growing, health education business. Driven by a mutual goal of strengthening Dr. Mau's social reach and impact and further developing strategic partnerships, this alliance is poised to advance his brand profile within the healthcare and wellness industries.

Key Points: 
  • "I am genuinely excited to partner with Fastlane to amplify my mission and message and reach a broader audience.
  • A Fastlane specialty is identifying untapped opportunities within specific market segments and devising targeted strategies to produce positive business outcomes.
  • "Fastlane is honored to partner with such a high profile and well-respected healthcare practitioner and thought leader like Dr. Mau," said Chris Faust, Founder and CEO of Fastlane.
  • Fastlane and Dr. Mau's collaboration marks a significant step towards bridging the information gap and advancing communications in the healthcare industry.

The Inner Circle acknowledges Leslie M. Boyden as a Top Pinnacle Professional

Retrieved on: 
tisdag, april 9, 2024
Alzheimer's disease, FOX, Small business, Cure, Retirement, CBS MoneyWatch, Radio, Animal, News, CBS News, Insurance, CBS, Lions Clubs International, Growth, Information technology, Lion, Financial planner, Society, Television, Nationwide, Consultant, Inner circle, Philosophy, Organization, Knowledge, American Heart Association, Management

PORT REPUBLIC, Md., April 9, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Leslie M. Boyden is acknowledged as a Top Pinnacle Professional for her contributions as a Renowned Financial Expert.

Key Points: 
  • PORT REPUBLIC, Md., April 9, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Leslie M. Boyden is acknowledged as a Top Pinnacle Professional for her contributions as a Renowned Financial Expert.
  • Mrs. Boyden, a distinguished figure in the financial services industry with over 15 years of experience, specializes in retirement planning.
  • Mrs. Boyden's expertise is not limited to her professional life; she is also an accomplished author, having penned "Retirement Conquered" in 2022.
  • Mrs. Boyden acknowledges her husband, Carl Boyden, and father, Eric Coon, for their unwavering support.

Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Retrieved on: 
tisdag, april 2, 2024
Hypertrophy, Heart, CRDL, Patient, Mayo Clinic, PPAR, Agent handling, Cleveland Clinic, Fibrosis, European, Therapy, Myocarditis, Analysis, American Heart Association, Human, Massachusetts General Hospital, Pericarditis, MMT, Heart failure, American College, Safety, ODD, Cardiology, Clinical professor, Disease, Pericardium, Research, World Heart Federation, Management, University, Death, Pericardial effusion, Maverick, Reactive oxygen species, TSX, Priority review, FDA, Conversation, Financial statement, Inflammation, Fast Track, Calcium, Wound healing, API, Pharmaceutical industry

"Cardiol Therapeutics made important progress in 2023 and early 2024 as we pursued our primary objective of providing new therapeutic options to patients with poorly served heart diseases," said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics.

Key Points: 
  • "Cardiol Therapeutics made important progress in 2023 and early 2024 as we pursued our primary objective of providing new therapeutic options to patients with poorly served heart diseases," said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics.
  • In January 2023, Cardiol announced the first patient had been enrolled in the Company's Phase II open-label pilot study ("MAvERIC-Pilot") investigating the tolerance, safety, and efficacy of CardiolRx™ in patients with recurrent pericarditis.
  • In November 2023, Cardiol announced that it had exceeded 50% of the patient enrollment target for the MAvERIC-Pilot study.
  • In January 2024, Cardiol announced that ARCHER had exceeded 50% patient enrollment and was progressing ahead of the original study timeline.

The American Journal of Managed Care® (AJMC®)’s Institute for Value-Based Medicine® (IVBM®) hosts event to highlight treatment options for obesity and minimizing risk of type 2 diabetes and cardiovascular disease

Retrieved on: 
fredag, april 5, 2024
American Heart Association, Cardiovascular disease, Obesity, Public health, UH, Type 2 diabetes, Risk, Partnership, DSM-IV codes, Integration, Harvard University, American Journal, Central nervous system, Diabetes, Health, Research, Travel, Neuroendocrinology, Role, Doctor of Public Health, MBA, WTW, Campbell University, CINEMA, MSL

The Institute for Value-Based Medicine® (IVBM®) has gained recognition for advocating value-based care and advancing health care methodologies.

Key Points: 
  • The Institute for Value-Based Medicine® (IVBM®) has gained recognition for advocating value-based care and advancing health care methodologies.
  • The upcoming event will showcase a panel of health care experts engaging in discussions about the latest advancements in the fields of value-based care and population health practices.
  • The event aims to acknowledge and explore the challenges within these domains.
  • Their invaluable insights and contributions will enrich the event, making it an exceptional platform for cutting-edge discussions in the health care landscape.

Beyond Meat® Unveils New and Expanded Line of Beyond Crumbles, Now Certified by the American Heart Association’s Heart-Check Program and the American Diabetes Association’s Better Choices for Life Program

Retrieved on: 
torsdag, mars 28, 2024
American Heart Association, Health, LDL, Certification, Cardiovascular disease, Taste, BYND, Nutrition, TMAO, Nutrient, Diabetes, American Journal, American Cancer Society, Stroke, Crumble, Beyond Meat, Sodium, Food, Death, Risk, Breakfast, Diet, American Diabetes Association, Beyond, Reference Daily Intake, Lunch, Cholesterol, American Heart, Dietary supplement

Convenient and easy to prepare, simply sauté the crumbles for four minutes in a skillet before adding them to your favorite dish or sauce.

Key Points: 
  • Convenient and easy to prepare, simply sauté the crumbles for four minutes in a skillet before adding them to your favorite dish or sauce.
  • Beyond Crumbles’ strong nutritional profile, coupled with its simple and clean ingredient list, earned the product certification by the American Heart Association’s Heart-Check program and the American Diabetes Association’s Better Choices for Life program,” said Beyond Meat Founder and CEO Ethan Brown.
  • As part of Beyond Meat’s commitment to innovating for human health, this announcement follows Beyond Steak’s earlier certifications by the American Heart Association and the American Diabetes Association .
  • With 1.2 million Americans diagnosed with diabetes every year , the Better Choices for Life Program uses the American Diabetes Association’s evidence-based guidelines to help consumers make informed choices about the foods they purchase.

United States Cardiovascular Devices Market, Size, Share, Forecast 2024-2030 Featuring Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Cardinal Health, Medtronic, GE, J&J, & Siemens - ResearchAndMarkets.com

Retrieved on: 
måndag, april 8, 2024
Health, Medical Devices, Cardiology, Hospital, Cardiac catheterization, Disease, American Heart Association, Stent, Cardiovascular disease, Coronary artery disease, Prevalence, Biotechnology, CVD, ECG, Incidence, Diabetes, Electrocardiography, Public, Research, Mortality, Insight, Death, Risk, Arrhythmia, Diagnosis, Heart failure, CAD, Medical device

Consequently, producers are investing in innovation and developing new cardiovascular devices to satisfy growing healthcare wishes, expanding the increase in the United States cardiovascular devices market.

Key Points: 
  • Consequently, producers are investing in innovation and developing new cardiovascular devices to satisfy growing healthcare wishes, expanding the increase in the United States cardiovascular devices market.
  • Technology is pivotal in employing growth in the United States cardiovascular devices market.
  • Numerous market players actively enforce strategic tasks, propelling an increase in the United States cardiovascular devices market.
  • In the United States cardiovascular devices market, diagnostics and monitoring devices have a significant presence
    The United States cardiovascular device market is broken up by device type into Diagnostics and Monitoring Devices and Therapeutic and Surgical Devices.

BD Named a Best Employer for Excellence in Employee Well-Being

Retrieved on: 
tisdag, april 9, 2024
Well, American Heart Association, Health, Culture, Job satisfaction, Health equity, BDX, Mental health, Cigna, Gold, Workforce, Safety, Management

BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.

Key Points: 
  • BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.
  • "Our integrated approach focuses on physical, emotional, financial and social well-being, and empowers our people to thrive—personally and professionally."
  • This award is the latest accolade for BD employee well-being efforts.
  • Additionally, the American Heart Association awarded BD a Gold level recognition for its commitments to employee health and well-being as measured in the Association's 2023 Well-being Works Better Scorecard.

Athletes for AEDs™ Hosts Inspirational Sports and Heart Health Event and Final Four Watch Party in Phoenix

Retrieved on: 
fredag, april 5, 2024
Emergency, American Heart Association, Cardiac arrest, Sport, National Football League, Education, Knowledge, Life, Zoll, Survivor, CPR, State Farm Arena, AED, Multimedia, NFL, NIL, For

PHOENIX, April 5, 2024 /PRNewswire-PRWeb/ -- Athletes for AEDs™, a dedicated advocate for heart health awareness and lifesaving skills in cardiac emergencies, is excited to announce its upcoming event and watch party during the final four weekend in Phoenix, Arizona.

Key Points: 
  • Athletes for AEDs™, a dedicated advocate for heart health awareness and lifesaving skills in cardiac emergencies, is excited to announce its upcoming event and watch party during the final four weekend in Phoenix, Arizona.
  • PHOENIX, April 5, 2024 /PRNewswire-PRWeb/ -- Athletes for AEDs™, a dedicated advocate for heart health awareness and lifesaving skills in cardiac emergencies, is excited to announce its upcoming event and watch party during the final four weekend in Phoenix, Arizona.
  • "Our event is not only about sports and fun; it's about saving lives and creating a safer, more prepared community."
  • Heart health is paramount, especially for young athletes, as undiagnosed heart conditions can have devastating consequences during physical activity.

Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer

Retrieved on: 
måndag, mars 25, 2024
Mechanical, SAS, American Heart Association, Percutaneous aortic valve replacement, Product marketing, Abbott Laboratories, Massachusetts Institute of Technology, Business, Patient, Business development, LAA, Medtronic, MD, Senior, Master, Retirement, TAVR, Marketing, Management

Paris, France and Munich, Germany, March 25, 2024 – TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO).

Key Points: 
  • Paris, France and Munich, Germany, March 25, 2024 – TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO).
  • In conjunction with this, and following eight years at the helm of the business, Helmut Straubinger is retiring as President & CEO.
  • Ahmed Elmouelhi is a seasoned professional with more than 20 years of medical device experience across strategy, sales and marketing, R&D, and clinical science.
  • Before joining TRiCares, Ahmed served as the Senior Vice President of Product Marketing, Strategy, and Business Development at AtriCure.

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

Retrieved on: 
torsdag, mars 21, 2024
Research, American Heart Association, Letter, Arrhythmia, Refusal, Offering, Paroxysmal supraventricular tachycardia, Safety, Atrial fibrillation, New Drug Application, Patient, Shanda, NDA, Aes, Science, Net, RTF, Investment, AHA, Milestone, Revera, FDA, Pharmaceutical industry

MONTREAL and CHARLOTTE, N.C., March 21, 2024 (GLOBE NEWSWIRE) --  Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a regulatory and corporate update.

Key Points: 
  • - FDA reiterated prior guidance on regulatory pathway for AFib-RVR, End of Phase 2 Meeting expected mid-2024
    MONTREAL and CHARLOTTE, N.C., March 21, 2024 (GLOBE NEWSWIRE) --  Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a regulatory and corporate update.
  • There was no revenue recorded for the fourth quarter of 2023, compared with $3.5 million the fourth quarter of 2022.
  • Commercial expense for the fourth quarter of 2023 was $5.0 million, compared with $2.6 million for the prior year period.
  • For the fourth quarter of 2023, net loss was $13.6 million, compared to $13.2 million for the prior year period.